Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10009-10014
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10009
Table 1 Prescription of antithrombotic agents
Anticoagulantsn
Warfarin68
Dabigatran12
Rivaroxaban3
Antiplatelets
Aspirin93
Clopidogrel35
Cilostazol31
Ticlopidine12
Others28
Anticoagulants + antiplatelets28
Dual antiplatelets59
Triple antiplatelets8
Heparin bridge73
Table 2 Characteristics of the study cohort and polyps n (%)
No bleedingBleedingP value
No. of patients759 (96.3)29 (3.7)
Age (yr, mean)64 ± 14.362 ± 16.00.50
GenderMale458 (98.1)9 (1.9)0.35
Female301 (93.8)20 (6.2)
Polyp locationRight239 (95.6)11 (4.4)0.93
Left336 (95.5)16 (4.5)
Polyp size≥ 10 mm338 (96.8)11 (3.2)0.43
< 10 mm361 (95.8)16 (4.2)
Polyp shapeFlat266 (96.7)9 (3.3)0.73
Sessile416 (96.5)15 (3.5)
Pedunculated118 (95.2)6 (4.8)
No. of polyps resected1343 (96.6)12 (3.4)0.69
≥ 2416 (96.1)17 (3.9)
Prophylactic clippingYes566 (95.8)25 (4.2)0.16
No193 (98.0)4 (2.0)
Resection methodPolypectomy or EMR703 (96.6)25 (3.4)0.20
ESD56 (93.3)4 (6.7)
AntiplateletsYes146 (94.8)8 (5.2)0.27
No613 (96.7)21 (3.3)
AnticoagulantsYes72 (86.7)11 (13.3)< 0.001
No687 (97.4)18 (2.6)
Heparin bridgeYes63 (86.3)10 (13.7)< 0.001
No696 (97.3)19 (2.7)
Antiplatelets + heparin bridgeYes32 (91.4)3 (8.6)0.11
No727 (96.5)26 (3.5)
Anticoagulants + heparin bridgeYes47 (82.5)10 (17.5)< 0.001
No712 (97.4)19 (2.6)
Table 3 Multivariate analysis of risk factors for Post-polypectomy bleeding
VariableOdds ratio95%CIP value
Anticoagulants4.2271.126-15.8720.033
Heparin bridge therapy2.1720.556-8.4820.265
Anticoagulants+ heparin bridge9.7963.771-25.443< 0.001
Table 4 Summary of 11 post-polypectomy bleeding cases taking anticoagulants
Anticoagu-lantsAntiplateletsHeparinOnset ofPT-INRAnticoagulantsAPTTHeparin
bridgePPB (POD)at PPBat PPBat PPBat PPB
1WarfarinClopidogrelYes51.62Yes93.1Yes
2Warfarin-Yes21.31Yes42.8Yes
3Warfarin-Yes61.26Yes32.2No
4WarfarinAspirinYes2, 51.20Yes29.4Yes
5Warfarin-Yes51.25Yes73.1Yes
6Dabigatran-No22.03---
7Warfarin-Yes1, 21.31No45.2Yes
8Dabigatran-Yes61.40-50.1No
9Warfarin-Yes1, 61.23No33.5Yes
10WarfarinAspirinYes21.32Yes40.4Yes
(Continued)
11Warfarin-Yes11.21Yes29.5Yes